Outcome selection for tissue-agnostic drug trials for immune-mediated inflammatory diseases: a systematic review of core outcome sets and regulatory guidance.
Olalekan Lee AiyegbusiLavinia Ferrante di RuffanoAmeeta RetzerPhilip N NewsomeChristopher D BuckleyMelanie J CalvertPublished in: Trials (2022)
Not registered.